Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Establishment and mutation analysis of a novel malignant peritoneal mesothelioma cell line, TU-MM-1, using whole genome sequencing.

Human cell - 1 Jan 2016

Oumi Nao, Itamochi Hiroaki, Komatsu Hiroaki, Oishi Tetsuro, Shimada Muneaki, Sato Shinya, Chikumi Jun, Sato Seiya, Nonaka Michiko, Kudoh Akiko, Harada Tasuku

Abstract excerpt

A new cell line of human malignant peritoneal mesothelioma (MPM), TU-MM-1, was established and characterized. The cells showed polygonal morphology, grew in monolayers without contact inhibition and were arranged like a jigsaw puzzle. The chromosome numbers ranged from 41 to 44. A low rate of proliferation was observed and the doubling time was 67.9 h. Genomic DNA sequencing revealed that TU-MM-1 cells harbored...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenomatous Polyposis Coli Protein
Share to BRCA1 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mesothelioma

Share to Mesothelioma, Malignant

Share to Mice, Inbred BALB C

Share to Neoplasm Transplantation

Share to Peritoneal Neoplasms

Share to Tumor Suppressor Proteins

Source

Identifiers

PMID: 26070481
DOI: 10.1007/s13577-015-0120-8

Genes

BAP1
LATS2
APC
BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Establishment and mutation analysis of a novel malignant peritoneal mesothelioma cell line, TU-MM-1, using whole genome sequencing.PMID 26070481Read ↗

Establishment and Histopathological Study of Patient-derived Xenograft Models and Primary Cell Lines of Epithelioid Malignant Peritoneal MesotheliomaSemantic proximity Read ↗

Personalized Oncogenomics: Clinical Experience with Malignant Peritoneal Mesothelioma Using Whole Genome SequencingSemantic proximity Read ↗

Molecular Characterization of Peritoneal MesotheliomasSemantic proximity Read ↗

BAP1 Loss Predicts Therapeutic Vulnerability in Malignant Peritoneal MesotheliomaSemantic proximity Read ↗

Molecular alterations and potential actionable mutations in peritoneal mesothelioma: a scoping review of high-throughput sequencing studies.Semantic proximity Read ↗

BAP1 mutation is a frequent somatic event in peritoneal malignant mesothelioma.Semantic proximity Read ↗

BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesotheliomaSemantic proximity Read ↗

Molecular biology of malignant mesothelioma: a review.Semantic proximity Read ↗

Genome-wide profile of pleural mesothelioma versus parietal and visceral pleura: the emerging gene portrait of the mesothelioma phenotype.Semantic proximity Read ↗

CDKN2A and MTAP deletions in peritoneal mesotheliomas are correlated with loss of p16 protein expression and poor survivalSemantic proximity Read ↗

Inactivation of BAP1 and the Hippo Pathway Defines the Mutational Landscape of Peritoneal MesotheliomaSemantic proximity Read ↗

Recent Insights Emerging from Malignant Mesothelioma Genome SequencingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.